Study Challenges NeuroD1's Ability to Convert Microglia into Neurons
A new preprint study using genetic fate mapping and live two-photon imaging found that the transcription factor NeuroD1 does not reprogram microglia into neurons, contradicting previous claims. Earlier research had suggested NeuroD1 could induce cross-lineage conversion of glial cells into neurons, a finding that had generated significant interest as a potential brain regeneration strategy. The results raise serious questions about the validity of prior glia-to-neuron conversion studies and highlight the need for rigorous lineage-tracing methods in regenerative neuroscience.
Researchers used genetic fate mapping and two-photon live-cell imaging to track the fate of microglia ectopically expressing NeuroD1, a transcription factor previously reported to convert glial cells into neurons. The study found that cells expressing NeuroD1 retained their microglial identity regardless of whether brain injury preconditioning was applied, providing no evidence of cross-lineage conversion. Furthermore, overexpression of NeuroD1 in microglia did not promote recovery from brain injury, undermining a key proposed therapeutic benefit. The findings directly challenge earlier studies that had claimed NeuroD1 could reprogram microglia into functional neurons, a result that had attracted considerable attention in the field of regenerative medicine. The authors argue that without rigorous lineage-tracing and cell fate mapping, apparent neuronal conversion may reflect misidentification of cell types rather than true reprogramming. The study underscores broader methodological concerns in the glia-to-neuron conversion field, where several high-profile claims have faced reproducibility challenges. As a bioRxiv preprint, the findings have not yet undergone formal peer review.
What's missing
It is unclear whether the viral delivery system or expression levels of NeuroD1 used here are directly comparable to those in the contested prior work, which could be a relevant methodological caveat.
What different sources said
- bioRxivCenter
Lineage tracing and live-cell imaging reveal that NeuroD1 does not reprogram microglia into neurons
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.